Insights

We’re acknowledged for our strong market insight and technical know-how

News

Penningtons Manches Cooper appointed as legal advisor to Advanced Research + Invention Agency (ARIA)

28 November 2023
Read more
Insights

Penningtons Manches Cooper advises Imperial University spin-out SPARTA Biodiscovery on fundraise and industry partnership

1 November 2023
Read more
News

Penningtons Manches Cooper advises world-leading medical technology company OrganOx on £25 million fundraise

4 August 2023
Read more
Insights

The National Security and Investment Act – further guidance on notifications

18 May 2023
Read more
Insights

The National Security and Investment Act – a year on

2 February 2023
Read more
Insights

Penningtons Manches Cooper acts for SkinBioTherapeutics plc on placing and REX retail offer on AIM

5 January 2023
Read more
News

Penningtons Manches Cooper advises Seloxium on its spin-out from Oxford University

7 November 2022
Read more
News

Penningtons Manches Cooper advises Titian Software on majority investment from Battery Ventures

12 July 2022
Read more
News

Penningtons Manches Cooper advises US company Echo Healthcare on its cross-border acquisition of Immersive Interactive

17 June 2022
Read more
News

Penningtons Manches Cooper advises bioanalysis and toxicology laboratory Analytical Services International on acquisition by Forensic Access

23 March 2022
Read more
Insights

Corporate team advises on major cross-border life sciences transaction

27 October 2021
Read more
News

Penningtons Manches Cooper advises Oxford Cannabinoid Technologies Holdings plc on its main market IPO

21 May 2021
Read more